Barclays’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378M | Buy |
|
|||||
|
2025
Q1 | $378M | Sell |
|
|||||
|
2024
Q4 | $448M | Sell |
|
|||||
|
2024
Q3 | $784M | Buy |
|
|||||
|
2024
Q2 | $426M | Sell |
|
|||||
|
2024
Q1 | $598M | Buy |
|
|||||
|
2023
Q4 | $335M | Sell |
|
|||||
|
2023
Q3 | $535M | Buy |
|
|||||
|
2023
Q2 | $478M | Buy |
|
|||||
|
2023
Q1 | $268M | Sell |
|
|||||
|
2022
Q4 | $641M | Buy |
|
|||||
|
2022
Q3 | $402M | Buy |
|
|||||
|
2022
Q2 | $377M | Sell |
|
|||||
|
2022
Q1 | $586M | Sell |
|
|||||
|
2021
Q4 | $892M | Buy |
|
|||||
|
2021
Q3 | $625M | Buy |
|
|||||
|
2021
Q2 | $394M | Buy |
|
|||||
|
2021
Q1 | $311M | Sell |
|
|||||
|
2020
Q4 | $334M | Sell |
|
|||||
|
2020
Q3 | $524M | Buy |
|
|||||
|
2020
Q2 | $276M | Buy |
|
|||||
|
2020
Q1 | $274M | Sell |
|
|||||
|
2019
Q4 | $504M | Sell |
|
|||||
|
2019
Q3 | $465M | Sell |
|
|||||
|
2019
Q2 | $598M | Sell |
|
|||||
|
2019
Q1 | $623M | Buy |
|
|||||
|
2018
Q4 | $584M | Sell |
|
|||||
|
2018
Q3 | $626M | Sell |
|
|||||
|
2018
Q2 | $523M | Buy |
|
|||||
|
2018
Q1 | $474M | Buy |
|
|||||
|
2017
Q4 | $399M | Buy |
|
|||||
|
2017
Q3 | $331M | Buy |
|
|||||
|
2017
Q2 | $274M | Buy |
|
|||||
|
2017
Q1 | $259M | Buy |
|
|||||
|
2016
Q4 | $233M | Sell |
|
|||||
|
2016
Q3 | $266M | Sell |
|
|||||
|
2016
Q2 | $277M | Sell |
|
|||||
|
2016
Q1 | $239M | Sell |
|
|||||
|
2015
Q4 | $441M | Buy |
|
|||||
|
2015
Q3 | $426M | Buy |
|
|||||
|
2015
Q2 | $415M | Buy |
|
|||||
|
2015
Q1 | $382M | Buy |
|
|||||
|
2014
Q4 | $311M | Sell |
|
|||||
|
2014
Q3 | $328M | Buy |
|
|||||
|
2014
Q2 | $319M | Buy |
|
|||||
|
2014
Q1 | $338M | Sell |
|
|||||
|
2013
Q4 | $362M | Buy |
|
|||||
|
2013
Q3 | $298M | Sell |
|
|||||
|
2013
Q2 | $756M | Buy |
|